Regulation of Human CD27+IgM+B Cell Activation by Cis-Binding of the Inhibitory Molecule CD22 to CD22 Ligand (CD22L)

被引：1
|
作者：
Dijke, Esme [1 ,2 ]
Derkatz, Kim [1 ,2 ]
Pearcey, Jean [1 ,2 ]
Wong, Fred [1 ,2 ]
Motyka, Bruce [1 ,2 ]
West, Lori [1 ,2 ]
机构：
[1] Univ Alberta, Pediat, Edmonton, AB, Canada
[2] Univ Alberta, Alberta Transplant Inst, Edmonton, AB, Canada
来源：
TRANSPLANTATION | 2017年 / 101卷 / 05期
关键词：
D O I：
10.1097/01.tp.0000520297.36145.fc
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
115.5
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [31] CD22 on the human basophils bind differently to anti-CD22 of different manufacturers
    Han, K
    Kim, Y
    Lee, S
    Kang, CS
    CYTOMETRY, 2000, 40 (03): : 251 - 251
  • [32] the role of CD22 and other inhibitory co-receptors in B-cell activation
    Nitschke, L
    CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (03) : 290 - 297
  • [33] CD22 ASSOCIATES WITH THE HUMAN SURFACE IGM-B-CELL ANTIGEN RECEPTOR COMPLEX
    LEPRINCE, C
    DRAVES, KE
    GEAHLEN, RL
    LEDBETTER, JA
    CLARK, EA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3236 - 3240
  • [34] Abnormal levels of the a chain of the CD22 adhesion molecule may account for low CD22 surface expression in chronic lymphocytic leukemia
    Payelle-Brogard, B
    Dumas, G
    Magnac, C
    Lalanne, A
    Dighiero, G
    Vuillier, F
    LEUKEMIA, 2006, 20 (05) : 877 - 878
  • [35] Targeting CD22 for B-cell hematologic malignancies
    Xu, Jia
    Luo, Wenjing
    Li, Chenggong
    Mei, Heng
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [36] Difference in CD22 molecules in human B cells and basophils
    Toba, K
    Hanawa, H
    Fuse, I
    Sakaue, M
    Watanabe, K
    Uesugi, Y
    Higuchi, W
    Takahashi, M
    Aizawa, Y
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (03) : 205 - 211
  • [37] Targeting CD22 for the Treatment of B-Cell Malignancies
    Shah, Nikesh N.
    Sokol, Lubomir
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 225 - 236
  • [38] ASSOCIATION OF CD22 WITH THE B-CELL ANTIGEN RECEPTOR
    PEAKER, CJG
    NEUBERGER, MS
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (06) : 1358 - 1363
  • [39] Targeting CD22 for B-cell hematologic malignancies
    Jia Xu
    Wenjing Luo
    Chenggong Li
    Heng Mei
    Experimental Hematology & Oncology, 12
  • [40] Human CD22 cannot fully substitute murine CD22 functions in vivo, as shown in a new knockin mouse model
    Woehner, Miriam
    Born, Stefanie
    Nitschke, Lars
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (11) : 3009 - 3018
12345